Back to Search
DAVID ZENK, DO
DO
Internal Medicine Physician
NPI: 1194164509IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE
Class of 2013
Research & Publications (2)
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse.
PMID 16730060·Leuk Res·2006
3-trial
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer.
PMID 10717333·Lung Cancer·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 DES PERES RD, SUITE 310
DES PERES, MO 63131 - Phone
- (314) 821-1313
Quick Facts
- NPI
- 1194164509
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 2
Are you this provider?
Claim Your Profile